Simon Clark has joined Polpharma as vice-president of the management board and chief commercial officer...
Located in Poland, Polpharma is a significant European active pharmaceutical ingredient (API) producer with current good manufacturing practice (cGMP) compliant and US Food and Drug Administration (FDA) approved multipurpose facilities.
The company’s manufacturing site is located in the heart of Europe in an easy access location near Gdansk International Airport and seaports in Gdansk and Gdynia.
A completely rebuilt and modernised production facility for the production of API was put into operation in February 2017 to help meet Polpharma Pharmaceutical Works’ clients’ growing requirements in regards to quality and quantity.
With its high-quality products, a customer-centric approach and competetive production costs, API Polpharma is your trusthworthy partner of choice.
The firm offers solutions tailored to your needs, including:
- Development and production of generic API
- Custom synthesis and toll manufacturing
- Intellectual property guidance
- Regulatory compliance
- Development of new salts and polymorphic forms of API
- Adjusted particle size distribution (PSD)
- Non-infringing proces development
- Wide reaction classes in FDA-approved facilities
- Multipurpose production line
This white paper outlines Polpharma B2B's finished dosage formulations (FDF) that are currently under development. Products...
Polpharma B2B is a significant European active pharmaceutical ingredient (API) producer with current good manufacturing...
Polpharma B2B's team of experts will be pleased to meet you at the CPhI Worldwide...